ZXDB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.763200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.981200E-01
Normal-vs-Stage2
6.065400E-01
Normal-vs-Stage3
1.270010E-01
Normal-vs-Stage4
6.358800E-01
Stage1-vs-Stage2
9.561800E-01
Stage1-vs-Stage3
1.255670E-02
Stage1-vs-Stage4
4.371000E-01
Stage2-vs-Stage3
1.291620E-01
Stage2-vs-Stage4
4.310400E-01
Stage3-vs-Stage4
2.152400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.530600E-01
Normal-vs-AfricanAmerican
6.902000E-01
Normal-vs-Asian
5.151000E-01
Caucasian-vs-AfricanAmerican
8.731800E-01
Caucasian-vs-Asian
8.222200E-01
AfricanAmerican-vs-Asian
7.741400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.099400E-01
Normal-vs-Female
6.712600E-01
Male-vs-Female
3.192600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.279200E-01
Normal-vs-Age(41-60Yrs)
9.184600E-01
Normal-vs-Age(61-80Yrs)
4.748400E-01
Normal-vs-Age(81-100Yrs)
1.006550E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.104000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.964200E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.102800E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.195600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.457000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.034040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.476200E-01
Normal-vs-Daily Drinker
8.495800E-01
Normal-vs-Weekly Drinker
3.034600E-01
Normal-vs-Occasional Drinker
6.687000E-01
Normal-vs-Social Drinker
8.149200E-01
Non Drinker-vs-Daily Drinker
4.140400E-01
Non Drinker-vs-Weekly Drinker
7.444800E-01
Non Drinker-vs-Occasional Drinker
2.577800E-01
Non Drinker-vs-Social Drinker
1.273420E-01
Daily Drinker-vs-Weekly Drinker
3.574800E-01
Daily Drinker-vs-Occasional Drinker
8.988400E-01
Daily Drinker-vs-Social Drinker
8.953600E-01
Weekly Drinker-vs-Occasional Drinker
2.763400E-01
Weekly Drinker-vs-Social Drinker
1.688410E-01
Occasional Drinker-vs-Social Drinker
7.256600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.391800E-02
Normal-vs-Grade 2
5.998300E-02
Normal-vs-Grade 3
5.977500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.332000E-01
Grade 1-vs-Grade 3
8.590000E-01
Grade 1-vs-Grade 4
9.391800E-02
Grade 2-vs-Grade 3
8.607200E-01
Grade 2-vs-Grade 4
5.998300E-02
Grade 3-vs-Grade 4
5.977500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.612000E-01
Normal-vs-NonDiabetic
5.938600E-01
Diabetic-vs-NonDiabetic
2.088400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.318800E-01
Normal-vs-NoPancreatitis
5.441800E-01
Pancreatitis-vs-NoPancreatitis
3.397400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.341600E-01
Normal-vs-N1
6.123000E-01
N0-vs-N1
6.871000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.143800E-01
Normal-vs-TP53-NonMutant
6.946800E-01
TP53-Mutant-vs-TP53-NonMutant
3.832400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
